SMA News & Perspectives - January 25, 2019
Jan 25, 2019, 12:00 AM
We discuss how ZOLGENSMA could be more cost-effective than Spinraza. Also, Kevin Schaefer discusses an article that he wrote for the SMA News Today website regarding how much each of us have changed over the past 10 years.